Cytokinetics Inc (CYTK)

R&D Expense Growth

2.39%

Quarterly · Period ending:

CYTK logo

CYTK R&D Expense Growth

Latest reported2.39%
CYTK Quarterly R&D Growth (QoQ) (0.00% → 2.39%)
High-resolution chart · PNG

CYTK r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
2.3889%
-5.921%
2.3218%
-11.8352%
12.7332%
6.6347%
10.6569%
6.3005%
-2.4188%
-4.0082%
2.9613%
-0.7957%
4.7506%
5.8693%
19.5811%
9.8169%
24.3627%
5.6026%
-10.1949%
32.9089%
15.4685%
8.0079%
20.738%
11.0693%
0.2392%
18.5666%
-9.3677%
-15.7722%
2.0047%
1.1514%
8.8168%
-0.885%
-2.4983%
-15.6794%
5.2271%
25.9377%
2.6958%
2.7322%
5.0994%
83.7396%
-28.1587%
2.1511%
14.6405%
-8.5391%
41.0898%
2.0162%
-23.1261%
-2.7009%
-6.0288%
-9.6499%
2.8189%
8.8928%
25.5542%
-0.2435%
12.0482%
6.7459%
-5.7519%
1.6979%
-3.2842%
-15.4285%
14.5332%
0.1965%
-4.0432%
-6.7311%
12.8805%
-7.6766%
-0.3551%
-3.3817%
2.44%
-13.1735%
-15.1564%
-9.0181%
5.368%
1.0317%
5.6064%
-3.7083%
9.9311%
-4.1456%
3.917%
1.1132%
10.0391%
4.9464%
15.9412%
-7.7697%
-4.7262%
-6.2628%
17.892%
-2.1951%
4.156%
0%
0%
-100%
-6.0598%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.